Literature DB >> 19339695

Early chromatin unfolding by RUNX1: a molecular explanation for differential requirements during specification versus maintenance of the hematopoietic gene expression program.

Maarten Hoogenkamp1, Monika Lichtinger, Hanna Krysinska, Christophe Lancrin, Deborah Clarke, Andrew Williamson, Luca Mazzarella, Richard Ingram, Helle Jorgensen, Amanda Fisher, Daniel G Tenen, Valerie Kouskoff, Georges Lacaud, Constanze Bonifer.   

Abstract

At the cellular level, development progresses through successive regulatory states, each characterized by their specific gene expression profile. However, the molecular mechanisms regulating first the priming and then maintenance of gene expression within one developmental pathway are essentially unknown. The hematopoietic system represents a powerful experimental model to address these questions and here we have focused on a regulatory circuit playing a central role in myelopoiesis: the transcription factor PU.1, its target gene colony-stimulating-factor 1 receptor (Csf1r), and key upstream regulators such as RUNX1. We find that during ontogeny, chromatin unfolding precedes the establishment of active histone marks and the formation of stable transcription factor complexes at the Pu.1 locus and we show that chromatin remodeling is mediated by the transient binding of RUNX1 to Pu.1 cis-elements. By contrast, chromatin reorganization of Csf1r requires prior expression of PU.1 together with RUNX1 binding. Once the full hematopoietic program is established, stable transcription factor complexes and active chromatin can be maintained without RUNX1. Our experiments therefore demonstrate how individual transcription factors function in a differentiation stage-specific manner to differentially affect the initiation versus maintenance of a developmental program.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19339695      PMCID: PMC2714206          DOI: 10.1182/blood-2008-11-191890

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  67 in total

1.  C/EBPalpha binds and activates the PU.1 distal enhancer to induce monocyte lineage commitment.

Authors:  Christine Yeamans; Dehua Wang; Ido Paz-Priel; Bruce E Torbett; Daniel G Tenen; Alan D Friedman
Journal:  Blood       Date:  2007-08-01       Impact factor: 22.113

2.  Gata2, Fli1, and Scl form a recursively wired gene-regulatory circuit during early hematopoietic development.

Authors:  John E Pimanda; Katrin Ottersbach; Kathy Knezevic; Sarah Kinston; Wan Y I Chan; Nicola K Wilson; Josette-Renée Landry; Andrew D Wood; Anja Kolb-Kokocinski; Anthony R Green; David Tannahill; Georges Lacaud; Valerie Kouskoff; Berthold Göttgens
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-25       Impact factor: 11.205

3.  Transcriptional repression mediated by repositioning of genes to the nuclear lamina.

Authors:  K L Reddy; J M Zullo; E Bertolino; H Singh
Journal:  Nature       Date:  2008-02-13       Impact factor: 49.962

4.  Continuous single-cell imaging of blood generation from haemogenic endothelium.

Authors:  Hanna M Eilken; Shin-Ichi Nishikawa; Timm Schroeder
Journal:  Nature       Date:  2009-02-12       Impact factor: 49.962

5.  Whole-genome mapping of histone H3 Lys4 and 27 trimethylations reveals distinct genomic compartments in human embryonic stem cells.

Authors:  Xiao Dong Zhao; Xu Han; Joon Lin Chew; Jun Liu; Kuo Ping Chiu; Andre Choo; Yuriy L Orlov; Wing-Kin Sung; Atif Shahab; Vladimir A Kuznetsov; Guillaume Bourque; Steve Oh; Yijun Ruan; Huck-Hui Ng; Chia-Lin Wei
Journal:  Cell Stem Cell       Date:  2007-09-13       Impact factor: 24.633

6.  PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis.

Authors:  Gang Huang; Pu Zhang; Hideyo Hirai; Shannon Elf; Xiaomei Yan; Zhao Chen; Steffen Koschmieder; Yutaka Okuno; Tajhal Dayaram; Joseph D Growney; Ramesh A Shivdasani; D Gary Gilliland; Nancy A Speck; Stephen D Nimer; Daniel G Tenen
Journal:  Nat Genet       Date:  2007-11-11       Impact factor: 38.330

7.  Runx genes are direct targets of Scl/Tal1 in the yolk sac and fetal liver.

Authors:  Josette-Renée Landry; Sarah Kinston; Kathy Knezevic; Marella F T R de Bruijn; Nicola Wilson; Wade T Nottingham; Michael Peitz; Frank Edenhofer; John E Pimanda; Katrin Ottersbach; Berthold Göttgens
Journal:  Blood       Date:  2008-01-09       Impact factor: 22.113

8.  Runx1 is required for the endothelial to haematopoietic cell transition but not thereafter.

Authors:  Michael J Chen; Tomomasa Yokomizo; Brandon M Zeigler; Elaine Dzierzak; Nancy A Speck
Journal:  Nature       Date:  2009-01-07       Impact factor: 49.962

9.  Runx1-mediated hematopoietic stem-cell emergence is controlled by a Gata/Ets/SCL-regulated enhancer.

Authors:  Wade T Nottingham; Andrew Jarratt; Matthew Burgess; Caroline L Speck; Jan-Fang Cheng; Shyam Prabhakar; Eddy M Rubin; Pik-Shan Li; Jackie Sloane-Stanley; John Kong-A-San; Marella F T R de Bruijn
Journal:  Blood       Date:  2007-09-06       Impact factor: 22.113

10.  The haemangioblast generates haematopoietic cells through a haemogenic endothelium stage.

Authors:  Christophe Lancrin; Patrycja Sroczynska; Catherine Stephenson; Terry Allen; Valerie Kouskoff; Georges Lacaud
Journal:  Nature       Date:  2009-01-28       Impact factor: 49.962

View more
  56 in total

Review 1.  Epigenetic mechanisms and developmental choice hierarchies in T-lymphocyte development.

Authors:  Ellen V Rothenberg
Journal:  Brief Funct Genomics       Date:  2013-08-06       Impact factor: 4.241

2.  CBFβ-SMMHC Inhibition Triggers Apoptosis by Disrupting MYC Chromatin Dynamics in Acute Myeloid Leukemia.

Authors:  John Anto Pulikkan; Mahesh Hegde; Hafiz Mohd Ahmad; Houda Belaghzal; Anuradha Illendula; Jun Yu; Kelsey O'Hagan; Jianhong Ou; Carsten Muller-Tidow; Scot A Wolfe; Lihua Julie Zhu; Job Dekker; John Hackett Bushweller; Lucio Hernán Castilla
Journal:  Cell       Date:  2018-06-28       Impact factor: 41.582

Review 3.  Blood cell generation from the hemangioblast.

Authors:  Christophe Lancrin; Patrycja Sroczynska; Alicia G Serrano; Arnaud Gandillet; Cristina Ferreras; Valerie Kouskoff; Georges Lacaud
Journal:  J Mol Med (Berl)       Date:  2009-10-25       Impact factor: 4.599

Review 4.  Transcriptional regulation of fetal to adult hemoglobin switching: new therapeutic opportunities.

Authors:  Andrew Wilber; Arthur W Nienhuis; Derek A Persons
Journal:  Blood       Date:  2011-02-14       Impact factor: 22.113

5.  Extravascular endothelial and hematopoietic islands form through multiple pathways in midgestation mouse embryos.

Authors:  Amanda D Yzaguirre; Nancy A Speck
Journal:  Dev Biol       Date:  2016-04-20       Impact factor: 3.582

6.  Distinct temporal requirements for Runx1 in hematopoietic progenitors and stem cells.

Authors:  Joanna Tober; Amanda D Yzaguirre; Eileen Piwarzyk; Nancy A Speck
Journal:  Development       Date:  2013-08-07       Impact factor: 6.868

Review 7.  Eukaryotic enhancers: common features, regulation, and participation in diseases.

Authors:  Maksim Erokhin; Yegor Vassetzky; Pavel Georgiev; Darya Chetverina
Journal:  Cell Mol Life Sci       Date:  2015-02-26       Impact factor: 9.261

8.  Poly(C)-Binding Protein Pcbp2 Enables Differentiation of Definitive Erythropoiesis by Directing Functional Splicing of the Runx1 Transcript.

Authors:  Louis R Ghanem; Andrew Kromer; Ian M Silverman; Xinjun Ji; Matthew Gazzara; Nhu Nguyen; Gabrielle Aguilar; Massimo Martinelli; Yoseph Barash; Stephen A Liebhaber
Journal:  Mol Cell Biol       Date:  2018-07-30       Impact factor: 4.272

Review 9.  Transcription factors: from enhancer binding to developmental control.

Authors:  François Spitz; Eileen E M Furlong
Journal:  Nat Rev Genet       Date:  2012-08-07       Impact factor: 53.242

10.  RUNX1a enhances hematopoietic lineage commitment from human embryonic stem cells and inducible pluripotent stem cells.

Authors:  Dan Ran; Wei-Jong Shia; Miao-Chia Lo; Jun-Bao Fan; David A Knorr; Patrick I Ferrell; Zhaohui Ye; Ming Yan; Linzhao Cheng; Dan S Kaufman; Dong-Er Zhang
Journal:  Blood       Date:  2013-01-31       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.